Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104

DNA Vaccines: Immunology, Application, and Optimization

Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,198

Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation

Huang, M., Khor, E., & Lim, L. Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016249.52831.a5 · Cited by 853

Chitosan as a novel nasal delivery system for vaccines

Illum, L., Jabbal‐Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 764

The Population Dynamics and Control of Tuberculosis

Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 609

DNA-polycation nanospheres as non-viral gene delivery vehicles

Leong, K. W., Mao, H., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00252-6 · Cited by 538

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

Vila, A., Sánchez, A., Janes, K. A., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449

Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport

Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 377

ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis

Brandt, L., Elhay, M. J., Rosenkrands, I., Lindblad, E. B., & Andersen, P. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.791-795.2000 · Cited by 336

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

Sette, A., & Fikes, J. D. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00083-9 · Cited by 323

Nanoparticle vaccines

Zhao, L., Seth, A., Wibowo, N., Zhao, C., Mitter, N., Yu, C., & Middelberg, A. P. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 952

Biomedical Applications of Chitosan and Its Derivative Nanoparticles

Zhao, D., Yu, S., Sun, B., Gao, S., Guo, S., & Zhao, K. (2018) · Polymers · doi:10.3390/polym10040462 · Cited by 607

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520

Nanoparticle Vaccines Against Infectious Diseases

Pati, R., Shevtsov, M. A., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 521

Nanoparticle-Based Delivery Systems for Vaccines

Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. K. (2022) · Vaccines · doi:10.3390/vaccines10111946 · Cited by 276

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

Fries, C. N., Curvino, E. J., Chen, J., Permar, S. R., Fouda, G. G., & Collier, J. H. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0739-9 · Cited by 254

Nanoparticles and Vaccine Development

Kheirollahpour, M., Mehrabi, M., Dounighi, N. M., Mohammadi, M., & Masoudi, A. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666191024162042 · Cited by 195

Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation

Chattopadhyay, S., Chen, J.-Y., Chen, H., & Hu, C. J. (2017) · Nanotheranostics · doi:10.7150/ntno.19796 · Cited by 171

Advancements in prophylactic and therapeutic nanovaccines

Bhardwaj, P., Bhatia, E., Sharma, S., Ahamad, N., & Banerjee, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.020 · Cited by 156

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy

Han, X., Alu, A., Liu, H., Shi, Y., Wei, X., Cai, L., & Wei, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.011 · Cited by 165

Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients

Itani, R., Tobaiqy, M. A., & Faraj, A. A. (2020) · Theranostics · doi:10.7150/thno.46691 · Cited by 146

Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases

Torres-Sangiao, E., Holban, A. M., & Gestal, M. C. (2016) · Molecules · doi:10.3390/molecules21070867 · Cited by 131

Recent advances on chitosan as an adjuvant for vaccine delivery

Dmour, I. M., & Islam, N. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.129 · Cited by 123

Nanoengineering of vaccines using natural polysaccharides

Cordeiro, A. S., Alonso, M. J., & de la Fuente, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.010 · Cited by 117

Evaluation of antibacterial efficiency of chitosan and chitosan nanoparticles on cariogenic Streptococci: an in vitro study

Aliasghari, A., Khorasgani, M. R., Vaezifar, S., Rahimi, F., Younesi, H., & Khoroushi, M. (2016) · Europe PMC (PubMed Central) · doi:10.5281/zenodo.3342596 · Cited by 113

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity

Singha, S., Shao, K., Ellestad, K. K., Yang, Y., & Santamaría, P. (2018) · ACS Nano · doi:10.1021/acsnano.8b05950 · Cited by 114

The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant

Wang, J., Zhu, R., Gao, B., Wu, B., Li, K., Sun, X., Liu, H., & Wang, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.060 · Cited by 108

Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale

Rosenthal, J. A., Chen, L., Baker, J. L., Putnam, D. A., & DeLisa, M. P. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.11.005 · Cited by 95

DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy

Tiptiri-Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.004 · Cited by 94

Polymer nanotechnology based approaches in mucosal vaccine delivery: Challenges and opportunities

Sharma, R. K., Agrawal, U., Mody, N., & Vyas, S. P. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.004 · Cited by 91

Organic and inorganic nanoparticle vaccines for prevention of infectious diseases

Poon, C. J., & Patel, A. (2020) · Nano Express · doi:10.1088/2632-959x/ab8075 · Cited by 82

Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines?

Khademi, F., Taheri, R. A., Avarvand, A. Y., Vaez, H., Momtazi‐Borojeni, A. A., & Soleimanpour, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.035 · Cited by 67

Recent Advances and Future Perspectives in Polymer-Based Nanovaccines

Pippa, Ν., Gazouli, M., & Pispas, S. (2021) · Vaccines · doi:10.3390/vaccines9060558 · Cited by 66

Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems

Tahamtan, A., Ghaemi, A., Gorji, A., Kalhor, H. R., Sajadian, A., Tabarraei, A., Moradi, A., Atyabi, F., & Kelishadi, M. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0069-z · Cited by 63

Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria

Osterloh, A. (2022) · Vaccines · doi:10.3390/vaccines10050751 · Cited by 63

Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks

Tatara, A. M. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0094 · Cited by 53

Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions

Wu, H., Fu, X., Zhai, Y., Gao, S., Yang, X., & Zhai, G. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100299 · Cited by 48

Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective

Gholap, A. D., Gupta, J., Kamandar, P. A., Bhowmik, D. D., Rojekar, S. V., Faiyazuddin, M., Hatvate, N. T., Mohanto, S., Ahmed, M. G., Subramaniyan, V., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01247 · Cited by 45

Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine

Chehelgerdi, M., & Doosti, A. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00618-1 · Cited by 44

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

Xu, K., Liang, Z. C., Ding, X., Hu, H., Liu, S., Nurmik, M., Bi, S., Hu, F.-S., Ji, Z., Ren, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700509 · Cited by 44

Prophylactic vaccine delivery systems against epidemic infectious diseases

Pan, C., Yue, H., Zhu, L., Ma, G., & Wang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113867 · Cited by 43

Nano-antimicrobials: A new paradigm for combating mycobacterial resistance.

Minakshi, P., Ghosh, M., Brar, B., Kumar, R., Lambe, U., Ranjan, K., Prasad, G., & Manoj, J. (2019) · Current pharmaceutical design · doi:10.2174/1381612825666190620094041 · Cited by 18

Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development

Tejeda‐Mansir, A., García‐Rendón, A., & Guerrero‐Germán, P. (2018) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2018.1560552 · Cited by 32

Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives

Chen, M., Shou, Z., Jin, X., & Chen, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2089294 · Cited by 34

DNA vaccines against tuberculosis

Bruffaerts, N., Huygen, K., & Romano, M. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.951630 · Cited by 31

Recent progress in the design of DNA vaccines against tuberculosis

Sefidi-Heris, Y., Jahangiri, A., Mokhtarzadeh, A., Shahbazi, M., Khalili, S., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Hejazi, M., Hashemzaei, M., et al. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.005 · Cited by 30

Development of New Preventive and Therapeutic Vaccines for Tuberculosis

Kwon, B.-E., Ahn, J.-H., Min, S., Kim, H., Seo, J., Yeo, S.-G., & Ko, H. (2018) · Immune Network · doi:10.4110/in.2018.18.e17 · Cited by 30

Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.

Khademi, F., Derakhshan, M., Avarvand, A. Y., & Tafaghodi, M. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.22059.5648 · Cited by 28

Engineered biomaterials for development of nucleic acid vaccines

Yang, H. J., Li, Y., Jin, S., Xu, J., Wang, P. C., Liang, X., & Zhang, X. (2015) · Biomaterials Research · doi:10.1186/s40824-014-0025-8 · Cited by 23

Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review

Danaeifar, M., Negahdari, B., Eslam, H. M., Zare, H., Ghanaat, M., Koushali, S. S., & Malekshahi, Z. V. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03383-x · Cited by 29

Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines

Peletta, A., Lemoine, C., Courant, T., Collin, N., & Borchard, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106699 · Cited by 21

Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation

Desai, D. N., Mahal, A., Varshney, R., Obaidullah, A. J., Gupta, B., Mohanty, P., Pattnaik, P., Mohapatra, N. C., Mishra, S., Kandi, V., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c02030 · Cited by 20

Nanoscience versus Viruses: The SARS‐CoV‐2 Case

Gościańska, J., Freund, R., & Wuttke, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107826 · Cited by 21

Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes

Lin, Q., Zhou, M., Xu, Z., Khanniche, A., Shen, H., & Wang, C. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.008 · Cited by 20

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

Kazakova, A., Zhelnov, P., Sidorov, R. Y., Rogova, A. S., Vasileva, O., Ivanov, R. A., Reshetnikov, V. V., & Muslimov, A. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457327 · Cited by 21

Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape

Luo, X., Zeng, X., Gong, L., Ye, Y., Sun, C., Chen, T., Zhang, Z., Tao, Y., Zeng, H., Zou, Q., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2120565 · Cited by 17

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment

Skwarek, A., Gąsecka, A., Jaguszewski, M. J., Szarpak, Ł., Dzieciątkowski, T., & Filipiak, K. J. (2021) · Archives of Medical Science · doi:10.5114/aoms/142103 · Cited by 17

Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses

Chen, W., Bao, Y., Chen, X., Burton, J. P., Gong, X., Gu, D., Mi, Y., & Bao, L. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0434-x · Cited by 17

Engineered nanoparticles as a precise delivery system in cancer therapeutics

Sharma, R. K., Agrawal, U., Mody, N., Dubey, S., & Vyas, S. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-41532-3.00013-0 · Cited by 16

Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19

Rahman, M. M., Ahmed, M., Islam, M. T., Khan, M. R., Sultana, S., Maeesa, S. K., Hasan, S., Hossain, M. A., Ferdous, K. S., Mathew, B., et al. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210701150315 · Cited by 17

Protective Effect of a Prime-Boost Strategy with the Ts87 Vaccine againstTrichinella spiralisInfection in Mice

Gu, Y., Zhan, B., Yang, Y., Yang, X., Zhao, X., Wang, L., Yang, J., Bi, K., Wang, Y., & Zhu, X. (2014) · BioMed Research International · doi:10.1155/2014/326860 · Cited by 16

Nanometric Biopolymer Devices for Oral Delivery of Macromolecules with Clinical Significance

Maiti, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00006-x · Cited by 16

Biodegradable nanomaterials

Anagnostou, K., Stylianakis, M. Μ., Michaleas, S., & Σκούρας, Α. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816705-2.00005-9 · Cited by 14

Tackling the Problem of Tuberculosis by Nanotechnology

Rai, M., Ingle, A. P., Bansod, S., & Kon, K. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801317-5.00009-8 · Cited by 14

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis

Maurya, S. K., Aqdas, M., Das, D. K., Singh, S., Nadeem, S., Kaur, G., & Agrewala, J. N. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05372-1 · Cited by 12

Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model

Gupta, J., Pathak, M., Misra, S., & Misra‐Bhattacharya, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142548 · Cited by 12

Chitosan-Based Nanocomposite as Targeted Drug Delivery Carrier

Selvasudha, N., Sweety, J. P., Dhanalekshmi, U. M., & Ruckmani, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-4787-1_4 · Cited by 11

Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease

Biswas, B., Misra, T. K., Ray, D., Majumder, T., Bandyopadhyay, T. K., & Bhowmick, T. K. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123018 · Cited by 10

The Influence of Nanoparticle on Vaccine Responses against Bacterial Infection

Bagheri-Josheghani, S., Bakhshi, B., & Peerayeh, S. N. (2022) · Journal of Nanotechnology · doi:10.1155/2022/6856982 · Cited by 10

A comprehensive analysis of predicted HLA binding peptides of JE viral proteins specific to north Indian isolates

Sharma, P., Saxena, K., Mishra, S. K., & Kumar, A. (2014) · Bioinformation · doi:10.6026/97320630010334 · Cited by 10

Chikungunya Virus Vaccine Development: Through Computational Proteome Exploration for Finding of HLA and cTAP Binding Novel Epitopes as Vaccine Candidates

Sharma, P., Sharma, P., Ahmad, S., & Kumar, A. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10347-0 · Cited by 10

Interactions of chitosan and its derivatives with cells (review)

Zubareva, A. A., & Svirshchevskaya, E. V. (2016) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683816050185 · Cited by 10

Effects of Nanoparticles on Viral Infection — A Review

Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A., & Alam, A. (2020) · NANO · doi:10.1142/s1793292020300030 · Cited by 9

Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model

Contreras-Magallanes, Y. G., Durán-Aguilar, M., Gallegos, S. L. S., Álvarez, Á. H., Andrade-Santillán, F. A., Bárcenas-Reyes, I., Ruíz, S. G., Rodríguez-Hernández, E., Cantó-Alarcón, G. J., & Milián-Suazo, F. (2021) · Animals · doi:10.3390/ani11041046 · Cited by 9

The emergence of nanovaccines as a new paradigm in virological vaccinology: a review

Baruah, C., Das, P., Devi, P., Saikia, P. M., & Deka, B. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00107 · Cited by 9

Top Down Computational Approach: A Vaccine Development Step to Find Novel Superantigenic HLA Binding Epitopes from Dengue Virus Proteome

Sharma, P., Sharma, P., Sheeba, & Kumar, A. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10184-1 · Cited by 8

Application of Nanotechnology in the Treatment of Infectious Diseases: An Overview

Mba, I. E., & Nweze, E. I. (2022) · Springer eBooks · doi:10.1007/978-981-16-9190-4_2 · Cited by 9

Nanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery

Johnson, L. M., Mecham, J. B., Quinn, F. D., & Hickey, A. J. (2019) · KONA Powder and Particle Journal · doi:10.14356/kona.2020013 · Cited by 8

Nanomaterials-based vaccines to target intracellular bacterial pathogens

Files, M. A., Kristjansson, K. M., Rudra, J. S., & Endsley, J. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1040105 · Cited by 6

Analysis of Promiscuous T cell Epitopes for Vaccine Development Against West Nile Virus Using Bioinformatics Approaches

Sharma, P., Sharma, P., Mishra, S. K., & Kumar, A. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9624-2 · Cited by 7

Biomedical applications of electrospun chitosan nanofibers

Moharir, K. S., Kurakula, M., Kale, V., Kenawy, E., Murtuja, S., Ahsan, M. N., Hasnain, M. S., & Nayak, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821058-1.00004-6 · Cited by 6

Biomimetic Nanovaccines: A Novel Approach in Immunization

Khojini, J. Y., Babaei, B., Shakarami, M., Mofidi, M., Tahershamsi, Z., Arjmand, T. F., Tajbakhsh, A., & Hayat, S. M. G. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230529094128 · Cited by 6

Advance in strategies to build efficient vaccines against tuberculosis

Qu, W., Guo, Y., Xu, Y. L., Zhang, J., Wang, Z., Ding, C., & Pan, Y. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.955204 · Cited by 5

Vaccine strategies against cystic fibrosis pathogens

Moigne, V. L., Herrmann, J., & Herrmann, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1102810 · Cited by 5

Sequence and Structure Based Binding Prediction Study of HLA Class I and cTAP Binding Peptides for Japanese Encephalitis Vaccine Development

Sharma, P., Srivastav, S., Mishra, S. K., & Kumar, A. (2016) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-016-9558-0 · Cited by 4

A Medico-Biological Approach to Chitosan Bionanocomposites

Khanna, N., Chatterji, T., Singh, S., & Khanna, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9646-7_3 · Cited by 3

The application of nanoparticle-based delivery systems in vaccine development

Rashidi, N., Nurgali, K., Apostolopoulos, V., & Davidson, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00001-1 · Cited by 3

Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies

Yaraghi, P., Kheyri, A., Mikaeili, N., Boroumand, A., Abbasifard, M., Farhangnia, P., Rezagholizadeh, F., & Khorramdelazad, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140558 · Cited by 3

DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments

Singh, A. K., & Malviya, R. (2022) · Current Gene Therapy · doi:10.2174/1566523223666221219094849 · Cited by 3

Tuberculosis and Nanotechnology: Where shall the Twain meet?

Shafiq, N., Malhotra, S., & Kondel, R. (2013) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1084 · Cited by 3

Role of Microbial Nanotechnology in Diagnostics

Minocha, S., Khadgawat, P., Bhattacharjee, A., Kumar, A., Tripathi, T., Pandey, S., & Tripathi, D. (2021) · Springer eBooks · doi:10.1007/978-981-16-1923-6_12 · Cited by 3

Construction and Immunological Evaluation of Immunostimulatory Nanocomposites with Vaccine Potential

Zhong, M., & Zhuang, G. (2017) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000339 · Cited by 2

Nanopartiküler Aşılar

DÖNMEZ, E., Dolgun, H. T. Y., & Kırkan, Ş. (2021) · Journal of Anatolian Environmental and Animal Sciences · doi:10.35229/jaes.970713 · Cited by 2

Therapeutic Applications of Nanotechnology in the Prevention of Infectious Diseases

Mazumdar, R., & Thakur, D. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-80371-1_10 · Cited by 2

Nanocarriers as delivery tool for COVID-19 drugs

Padhi, S., Azharuddin, M., Behera, A., Zakir, F., Mirza, M. A., Chyad, A. A., Iqbal, Z., & Mansoor, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95574-4.00018-4 · Cited by 2

Exploration of Biocompatibility and Toxicity of Nanomaterials in Diagnosis and Treatment of Infectious Diseases

Puvvada, N., Chandu, B., & Panigrahi, P. K. (2025) · Wiley eBooks · doi:10.1002/9781394200559.ch11 · Cited by 2

Chitosan based nanocarriers for delivery of therapeutic agents

Ogundolie, F. A., Babalola, O. O., Adebayo-Gege, G. I., Alabi, T. D., & Adetunji, C. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13997-0.00019-9 · Cited by 1

Evaluation and comparison of antimicrobial property of chitosan nanoparticles on nickel-titanium archwires: an in vivo study

PATEL, J., Sharma, P., & Patel, K. (2026) · Dental Press Journal of Orthodontics · doi:10.1590/2177-6709.31.1.e2625184.oar · Cited by 1

Functionalized chitosan-G-poly caprolactone vaccine delivery system fabricated to display antigen–antibody immune complexes of Mycobacterium tuberculosis elicits immune response in Ex-vivo model

Rajadas, S. E., Sounderrajan, V., Prabhakaran, R. A., Agrawal, R., Jeyadoss, L., Rajan, M., Parthasarathy, K., & Shakila, H. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00520-x · Cited by 1

Nanotechnology-based interventions for interactions with the immune system

Saha, S., Dasgupta, S., & Barui, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822858-6.00013-3 · Cited by 1

Construction of Eukaryotic Expression Vector and Expression on Mycobacterium bovis ag85a and mpb70 Genes

Hou, S., Wang, C. F., Zheng, Y. R., Guan, J. N., Lin, J. M., Gao, D. M., Gao, Y. H., Hong, X., & Jiang, X. (2013) · Applied Mechanics and Materials · doi:10.4028/www.scientific.net/amm.421.308

Follicular Helper, Follicular Regulatory T cells and the Germinal Center In HIV Vaccine Development

Dent, A. L. (2015) · International Journal of Vaccines and Immunization · doi:10.16966/2470-9948.e101

Local Pulmonary Host‐Directed Therapies for Tuberculosis via Aerosol Delivery

Juarrero, M. G. (2016) · doi:10.1002/9781118943182.ch16

Investigation into Self-Assembling Microcrystals as an alternative to polysaccharide-based conjugate vaccines

Lavelle, S.-W. (2016) · UCL Discovery (University College London)

Nanomedicine progress in prevention, detection, and treatment of tuberculosis

Marutescu, L. G., Frăţiean, D., & Chifiriuc, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816505-8.00011-4

Enfeksiyöz Nekrotik Hepatitis Aşısının Üretiminde Poli (D, L-Laktik-Ko-Glikolik Asit) (PLGA) Biyopolimerinin Adjuvant Etkisinin Araştırılması

AKINCI, Z., & Kalender, H. (2019) · Etlik Veteriner Mikrobiyoloji Dergisi · doi:10.35864/evmd.543182

Nanoparticle theranostics targeting CLEC14A on tumour vasculature

Pearce, J. (2020) · University of Birmingham Institutional Research Archive (University of Birmingham)

BCG Vaccine and New Approaches Against Prevention

KOÇ, A. N. (2014) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2014.123

A proteína ESAT-6 como medida profilática para o controle da tuberculose pulmonar: uma revisão sistemática

Santos, I. L. A. B. D., & Ferreira, E. D. S. (2023) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv21n10-197

Vaccine delivery systems for immunization

Askari, V. R., Yahyazadeh, R., & Rahimi, V. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00005-9

A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice

Jiang, Q., Zhang, J., Chen, X., Xia, M., Lu, Y., Wen, Q., Ganzhu, F., Zhao, D., Li, Y., He, F., et al. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120114 · Cited by 17

Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection

Yu, F., Wang, J., Dou, J., Yang, H., He, X., Xu, W., Zhang, Y., Hu, K., & Gu, N. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.02.015 · Cited by 55

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge

Gao, H., Yue, Y., Hu, L., Xu, W., & Xiong, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.093 · Cited by 23

ESAT-6 DNA vaccine for Mycobacterium tuberculosis and its humoral and T-cell response as well as its protective efficacy

Hong, C. (2003) · Zhongguo yufang shouyi xuebao

Open Access at PubMed Central

Jianga, Q., Zhanga, J., Chena, X., Xiaa, M., Lua, Y., Qiua, W., Fenga, G., Zhaoa, D., Lia, Y., Hea, F., et al. (2016)